Morning Rounds: Why health care costs are nearly a fifth of the GDP

Off Biotech, Business, CRISPR, diversity and inclusion, drug development, FDA, finance, government agencies, Health, Human Health, legal, Life Sciences, marijuana, Medicine, Morning Rounds, patients, Pharmaceuticals, public health, rare diseases, research, Science and Research

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.

Good morning. Don’t miss Nicholas Florko’s jaw-dropping investigation into medical marijuana businesses marketing their products for cancer or depression with no regulatory oversight.

Read the rest…

Read Original Article: Morning Rounds: Why health care costs are nearly a fifth of the GDP »

About The Author